Drug Database
J02AC04 posaconazole
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Noxafil 100 mg Gastro-resistant Tablets
- POM Noxafil 100 mg Gastro-resistant Tablets (Northern Ireland)
- POM Noxafil 300 mg concentrate for solution for infusion
- POM Noxafil 300 mg concentrate for solution for infusion (Northern Ireland)
- POM Noxafil 40mg/ml oral suspension
- POM Noxafil 40mg/ml oral suspension (Northern Ireland)
- POM Posaconazole 40 mg/ml oral suspension
- POM Posaconazole 40 mg/ml Oral Suspension
- POM Posaconazole Accord 100 mg gastro-resistant tablets
- POM Posaconazole AHCL 40 mg/mL oral suspension
- POM Posaconazole Biocon 100 mg gastro-resistant tablets
- POM Posaconazole Dr. Reddys 40 mg/ml Oral Suspension
- POM Posaconazole Mylan 100 mg gastro-resistant tablets
- POM Posaconazole Sandoz 100 mg gastro-resistant tablets
- POM Posaconazole STADA 100 mg Gastro-resistant tablets
- POM Posaconazole Zentiva 100 mg gastro-resistant tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).